Generated by AI
Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets nucleic acid-based testing technologies for infectious disease detection and related applications. Co-Diagnostics focuses on PCR-based solutions, including the Co-Dx PCR platform for point-of-care and at-home testing, as well as diagnostic tests for conditions such as COVID-19, influenza, tuberculosis, hepatitis, malaria, dengue, and other pathogens. The company also develops molecular tools for mosquito testing, agricultural pathogen detection, and genetic analysis in plant and animal genomes. Its proprietary Co-Primers technology is designed to support highly specific test development and simplify complex molecular testing workflows. Headquartered in Salt Lake City, Utah, Co-Diagnostics serves healthcare, public health, research, and agricultural markets through its diagnostics products and development platforms.
Website2401 S. Foothill Drive
Salt Lake City, UT, 84109
United States
The latest articles about CODX.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 10's posts. Generated by AI.
Summary of May 26's posts. Generated by AI.
Summary of Nov 10's posts. Generated by AI.
Investors talking about CODX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.